Table 5 Medications Administered to Patients Seen for Urgent/Unscheduled Follow-Up Visit Within 7 Days of an Intravitreal Injection
N = 441 | ||
|---|---|---|
Medication | Frequency UFU | Percentage UFU |
Aflibercept | 189 | 42.9 |
Ranibizumab | 35 | 7.9 |
Bevacizumab | 165 | 37.4 |
Dexamethasone intravitreal implant | 30 | 6.8 |
Triamcinolone acetonide | 10 | 2.3 |
Brolucizumab | 12 | 2.7 |
Fluocinolone acetonide intravitreal implant .19 mg | 0 | 0 |
Fluocinolone acetonide intravitreal implant .18 mg | 0 | 0 |